News and Announcements
Sales leadership for tech businesses offers pre-transaction assessment for Wholesale Investor clients
- Published January 27, 2023 5:34AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Investments are made with a view to growth. Investors are analytical in assessing legal, technical, intellectual property and finance. Sales is assessed based on indicators such as cost of acquisition and monthly recurring revenue. Hope is not a strategy for sales growth, so how do you assess:
- The Founder’s ability to lead scaling the business?
- The sales team’s ability to deliver predictable, sustainable results?
- The Founder’s plans to build and manage a high-performance sales team?
What are your options to build sales?
- Do you do this yourself?
- Have the Founder lead Sales?
- Hire an expensive sales leader?
Sales Director Central addresses these risks with two services for investors. The first service provides the investor with an analysis of the client’s sales unit. It is assessment against a multi-point checklist based on our proven sales framework and is benchmarked against our data set. The second service should be attached to your investment, delivering predictable, sustainable results. The fractional sales leadership service provides sales leadership, a sales framework and establishes/transforms a high-performance sales team.
For Wholesale Investor clients we offer a free pre-transaction assessment of the sales team’s ability to deliver predictable, sustainable results. Inquiries via our Criisp deal room.
Take a free simple self-assessment here.
About Sales Director Central
Through the power of sales, we unleash the potential of those crazy enough to believe they can change the world.
Our Promise – Predictable, Sustainable Results.
Predictable – through the deep experience of our sales leaders (mentors).
Sustainable – our proven sales framework is delivered through a fractional sales leadership model.
Connect with the company and learn more about Sales Director Central by accessing their deal room here.
Company Updates
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
